FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders, today announces that the Company has retained Christian Attar Law, a regional litigation firm located in Houston, Texas, to co-lead, along with Alan M. Pollack of the New York City law firm Warshaw Burstein, LLP (collectively, the "Partners"), an investigation of any potential naked short selling or other market manipulation of common shares of FSD Pharma.
The Company and its legal team intend to provide all evidence of and records of activity to the appropriate authorities (e.g., Department of Justice, Securities and Exchange Commission, Ontario Securities Commission).
https://finance.yahoo.com/news/fsd-pharma-retains-christian-attar-113000721.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.